Viking Global Opportunities Parent GP LLC, 10% Owner at Inhibrx Biosciences, Inc. (INBX), sold 700,000 shares at $32.25 ($22.6M) on 2025-10-07, disclosed to the SEC on 2025-10-09.
Open-market sale of $22.6M INBX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.25 | 16,315 | $526K | 2.3% |
| 2 | $32.25 | 16,315 | $526K | 2.3% |
| 3 | $32.25 | 25,042 | $808K | 3.6% |
| 4 | $32.25 | 25,042 | $808K | 3.6% |
| 5 | $32.25 | 308,643 | $10.0M | 44.1% |
| 6 | $32.25 | 308,643 |
| $10.0M |
| 44.1% |
| Total | $32.25 avg | 700,000 | $22.6M | 100% |